Powered 500 · 2026POWEREDS. 154 of 500
Sabrina Johnson founded Daré Bioscience in 2015 specifically to fill the pharmaceutical industry's long-neglected women's health gap, building a publicly traded portfolio spanning contraception, fertility, menopause, and bacterial vaginosis treatments including the FDA-approved Xaciato.
Sabrina Johnson is Founder and CEO of Dare Bioscience, a publicly traded women's health pharmaceutical company developing products for reproductive health and sexual wellness.
She founded Dare in 2015. The company's products include Xaciato (for bacterial vaginosis) and Ovaprene (a hormone-free contraceptive in development). She previously held leadership roles at WomanCare Global and Cypress Bioscience.
Interview · In Pipeline
Sponsored placement
An invitation, extended to Powered readers.
Drive the Continental GT S.
Request a test driveBentley T&Cs apply
